| 2, 4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer A Blomme, CA Ford, E Mui, R Patel, C Ntala, LE Jamieson, M Planque, ... Nature Communications 11 (1), 2508, 2020 | 124 | 2020 |
| Asporin is a fibroblast-derived TGF-β1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer P Maris, A Blomme, AP Palacios, B Costanza, A Bellahcène, E Bianchi, ... PLoS medicine 12 (9), e1001871, 2015 | 123 | 2015 |
| Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis MJ Nokin, F Durieux, P Peixoto, B Chiavarina, O Peulen, A Blomme, ... elife 5, e19375, 2016 | 118 | 2016 |
| Regulation of lipid metabolism by the unfolded protein response M Moncan, K Mnich, A Blomme, A Almanza, A Samali, AM Gorman Journal of cellular and molecular medicine 25 (3), 1359-1370, 2021 | 97 | 2021 |
| Myoferlin is a key regulator of EGFR activity in breast cancer A Turtoi, A Blomme, A Bellahcène, C Gilles, V Hennequière, P Peixoto, ... Cancer research 73 (17), 5438-5448, 2013 | 91 | 2013 |
| Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases A Blomme, G Van Simaeys, G Doumont, B Costanza, J Bellier, Y Otaka, ... Oncogene 37 (9), 1237-1250, 2018 | 79 | 2018 |
| Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer A Blomme, B Costanza, P De Tullio, M Thiry, G Van Simaeys, S Boutry, ... Oncogene 36 (15), 2116-2130, 2017 | 64 | 2017 |
| Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes A Blomme, K Fahmy, O Peulen, B Costanza, M Fontaine, I Struman, ... Oncotarget 7 (50), 83669, 2016 | 63 | 2016 |
| Transforming growth factor beta‐induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration B Costanza, G Rademaker, A Tiamiou, P De Tullio, J Leenders, ... International journal of cancer 145 (6), 1570-1584, 2019 | 61 | 2019 |
| In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development G Warnock, A Turtoi, A Blomme, F Bretin, MA Bahri, C Lemaire, LC Libert, ... Journal of Nuclear Medicine 54 (10), 1782-1788, 2013 | 56 | 2013 |
| Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies A Turtoi, A Blomme, D Debois, J Somja, D Delvaux, G Patsos, ... Hepatology 59 (3), 924-934, 2014 | 55 | 2014 |
| Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis B Chiavarina, B Costanza, R Ronca, A Blomme, S Rezzola, P Chiodelli, ... Theranostics 11 (4), 1626, 2021 | 52 | 2021 |
| Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues A Turtoi, B Dumont, Y Greffe, A Blomme, G Mazzucchelli, P Delvenne, ... Journal of proteome research 10 (7), 3160-3182, 2011 | 44 | 2011 |
| Proteomic and Functional Characterization of a Chlamydomonas reinhardtii Mutant Lacking the Mitochondrial Alternative Oxidase 1 G Mathy, P Cardol, M Dinant, A Blomme, S Gérin, M Cloes, B Ghysels, ... Journal of proteome research 9 (6), 2825-2838, 2010 | 43 | 2010 |
| Activation of β-catenin cooperates with loss of Pten to drive AR-independent castration-resistant prostate cancer R Patel, EA Brzezinska, P Repiscak, I Ahmad, E Mui, M Gao, A Blomme, ... Cancer Research 80 (3), 576-590, 2020 | 36 | 2020 |
| Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome A Turtoi, A Blomme, E Bianchi, P Maris, R Vannozzi, AG Naccarato, ... Journal of proteome research 13 (12), 5660-5669, 2014 | 36 | 2014 |
| Plasticity of the mitoproteome to nitrogen sources (nitrate and ammonium) in Chlamydomonas reinhardtii: the logic of Aox1 gene localization S Gérin, G Mathy, A Blomme, F Franck, FE Sluse Biochimica et Biophysica Acta (BBA)-Bioenergetics 1797 (6-7), 994-1003, 2010 | 36 | 2010 |
| HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies P Peixoto, A Blomme, B Costanza, R Ronca, S Rezzola, AP Palacios, ... Oncogene 35 (34), 4481-4494, 2016 | 35 | 2016 |
| Methylglyoxal scavengers resensitize KRAS-mutated colorectal tumors to cetuximab J Bellier, MJ Nokin, M Caprasse, A Tiamiou, A Blomme, JL Scheijen, ... Cell reports 30 (5), 1400-1416. e6, 2020 | 31 | 2020 |
| Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer A Almanza, K Mnich, A Blomme, CM Robinson, G Rodriguez-Blanco, ... Nature communications 13 (1), 2493, 2022 | 30 | 2022 |
